Evidence map›Paper›PMID 25486088›Full record

ReviewProgress in retinal and eye research2015

Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.

S Scott Whitmore, Elliott H Sohn, Kathleen R Chirco, Arlene V Drack, Edwin M Stone, Budd A Tucker, Robert F Mullins

Open access · greenAbstract readReview
In one paragraph

Review in Progress in retinal and eye research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 1 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 1 synthesis or guideline pooled it, 212 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Choriocapillaris in Age-Related Macular Degeneration.Turkish journal of ophthalmology · 2024
    Review
  17. Review
  18. Observational
  19. Review
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

S Scott WhitmoreThe Stephen A. Wynn Institute for Vision Research, The University of Iowa, United States; Department of Ophthalmology and Visual Sciences, The University of Iowa, United States.
Elliott H SohnThe Stephen A. Wynn Institute for Vision Research, The University of Iowa, United States; Department of Ophthalmology and Visual Sciences, The University of Iowa, United States.
Kathleen R ChircoThe Stephen A. Wynn Institute for Vision Research, The University of Iowa, United States; Department of Ophthalmology and Visual Sciences, The University of Iowa, United States.
Arlene V DrackThe Stephen A. Wynn Institute for Vision Research, The University of Iowa, United States; Department of Ophthalmology and Visual Sciences, The University of Iowa, United States.
Edwin M StoneThe Stephen A. Wynn Institute for Vision Research, The University of Iowa, United States; Department of Ophthalmology and Visual Sciences, The University of Iowa, United States.
Budd A TuckerThe Stephen A. Wynn Institute for Vision Research, The University of Iowa, United States; Department of Ophthalmology and Visual Sciences, The University of Iowa, United States.
Robert F MullinsThe Stephen A. Wynn Institute for Vision Research, The University of Iowa, United States; Department of Ophthalmology and Visual Sciences, The University of Iowa, United States.
University of Iowa · US

Funding

Choriocapillaris Protection and Replacement in AMDR01EY024605 · NEI · UNIVERSITY OF IOWA · PI Robert Foster Mullins, Budd A Tucker · 2014 to 2026
$4.6M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008629 · NIGMS · UNIVERSITY OF IOWA · PI EBERL, DANIEL F · 1997 to 2021
$4.1M
Molecular Genetics of Age Related Macular DegenerationR01EY016822 · NEI · UNIVERSITY OF IOWA · PI STONE, EDWIN M · 2005 to 2013
$4.0M
Development of a cell replacement therapy to treat retinal degenerative blindnessDP2OD007483 · OD · UNIVERSITY OF IOWA · PI TUCKER, BUDD A · 2010 to 2010
$2.3M
NEI NIH HHS EY-016822NEI NIH HHS EY-024605NEI NIH HHS R01 EY016822NEI NIH HHS R01 EY024605NIGMS NIH HHS T32 GM008629NIH HHS 1DP2OD007483NIH HHS DP2 OD007483
6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is a common and devastating disease that can result in severe visual dysfunction. Over the last decade, great progress has been made in identifying genetic variants that contribute to AMD, many of which lie in genes involved in the complement cascade. In this review we discuss the significance of complement activation in AMD, particularly with respect to the formation of the membrane attack complex in the aging choriocapillaris. We review the clinical, histological and biochemical data that indicate that vascular loss in the choroid occurs very early in the pathogenesis of AMD, and discuss the potential impact of vascular dropout on the retinal pigment epithelium, Bruch's membrane and the photoreceptor cells. Finally, we present a hypothesis for the pathogenesis of early AMD and consider the implications of this model on the development of new therapies.

Indexed as

AgingBruch MembraneChoroidComplement ActivationComplement System ProteinsHumansMacular DegenerationRetinal Pigment EpitheliumComplement System ProteinsAge-related macular degenerationChoriocapillarisChoroidmaculaComplement systemEndothelial cellsPathophysiology

Identifiers

PMID25486088
PMCPMC4339497
OpenAlexW2016996903

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.